This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Ping Liu
Associate Director, Cell Line Development at REGENXBIO


Ping obtained her Ph.D in Molecular Genetics and Biochemistry at Georgia State University and completed her postdoc training at Johns Hopkins University. She started her first industry job as a staff scientist for process development at Thermo Fisher. She worked as a technical lead for cell line development of antibodies and recombinant proteins in CHO system. After that she took a leadership role at Jecho Laboratories, Inc. where she worked as a process development group leader. Currently she is head of cell line development team in RGENXBIO where she leads efforts of vector design, cell line development and engineering to improve AAV production levels.

Agenda Sessions

  • Cell Line Development and Plasmid Optimization to Improve AAV Titers